According to AstraZeneca's latest financial reports the company's current earnings are โฌ54.07 Billion. , an increase over its 2023 earnings that were of โฌ7.90 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | โฌ9.66 B | 22.28% |
2023 | โฌ7.90 B | 122.77% |
2022 | โฌ3.54 B | 278.83% |
2021 | โฌ0.93 B | -80.51% |
2020 | โฌ4.80 B | 75.86% |
2019 | โฌ2.73 B | -12.18% |
2018 | โฌ3.11 B | -6.54% |
2017 | โฌ3.33 B | -26.94% |
2016 | โฌ4.55 B | 19.74% |
2015 | โฌ3.80 B | 86.05% |
2014 | โฌ2.04 B | -41.35% |
2013 | โฌ3.48 B | -54.57% |
2012 | โฌ7.68 B | -37.9% |
2011 | โฌ12.36 B | 11.18% |
2010 | โฌ11.12 B | 0% |
2009 | โฌ11.12 B | 31.29% |
2008 | โฌ8.47 B | 12.97% |
2007 | โฌ7.50 B | 0.97% |
2006 | โฌ7.42 B | 23.29% |
2005 | โฌ6.02 B | -2526.12% |
2004 | -โฌ0.25 Billion | -106.52% |
2003 | โฌ3.80 B | 3.54% |
2002 | โฌ3.67 B | -33.34% |
2001 | โฌ5.51 B | 49.57% |
2000 | โฌ3.69 B | |
1997 | โฌ2.09 B | -43.89% |
1996 | โฌ3.72 B | |
1994 | โฌ1.29 B | 22.61% |
1993 | โฌ1.05 B |